Eye Care Company Boosts Revenue Outlook Following Record Sales Growth

Irvine, Thursday, 6 August 2026.
Driven by a 69% surge in quarterly product sales, Tarsus Pharmaceuticals raised its full-year 2026 revenue outlook to $705 million while expanding its late-stage drug pipeline.